Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: PKP2-ACM Natural History Study

View source ↗

Summary

This entry notes that Rocket Pharmaceuticals is recruiting for a natural history study of PKP2-Arrhythmogenic Cardiomyopathy (PKP2-ACM) to better understand dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rocket Pharmaceuticals Inc. | Conditions: Cardiomyopathies, Heart Diseases | Status: RECRUITING